Skip to main content

The 5 Most Interesting Analyst Questions From Brookdale’s Q1 Earnings Call

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

BKD Cover Image

Brookdale’s first quarter was marked by a negative market reaction, driven primarily by revenue that came in below Wall Street expectations and ongoing operational disruptions tied to major company restructuring. Management cited the lingering effects of a comprehensive reorganization, including a new regional leadership structure and pivotal leadership changes, as key factors behind the slow start in January and February. CEO Nikolas Stengle emphasized, “the cumulative effect of all these changes did temporarily impact our results in Q4 and early Q1,” noting that winter storms and the absorption of significant annual in-place rate increases further weighed on occupancy and expense management early in the quarter.

Is now the time to buy BKD? Find out in our full research report (it’s free for active Edge members).

Brookdale (BKD) Q1 CY2026 Highlights:

  • Revenue: $764.9 million vs analyst estimates of $771.2 million (6% year-on-year decline, 0.8% miss)
  • Adjusted EPS: -$0.02 vs analyst estimates of -$0.09 (77.2% beat)
  • Adjusted EBITDA: $131.1 million vs analyst estimates of $135.8 million (17.1% margin, 3.5% miss)
  • EBITDA guidance for the full year is $509 million at the midpoint, in line with analyst expectations
  • Operating Margin: 8.1%, up from 3.9% in the same quarter last year
  • Market Capitalization: $3.10 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Brookdale’s Q1 Earnings Call

  • Brian Tanquilut (Jefferies) asked CFO Dawn Kussow about the ramp in quarterly EBITDA growth and confidence behind the acceleration, especially given RevPOR trends. Kussow cited seasonality and timing of cost savings, while CEO Nikolas Stengle highlighted operational changes and improved April occupancy as key drivers.
  • Brian Tanquilut (Jefferies) followed up on balancing RevPAR growth and move-outs, questioning whether higher move-outs are a concern. Stengle explained that the move-outs were expected due to January’s rate increases and emphasized strong pricing power and stickiness of the rate hikes.
  • Brian Tanquilut (Jefferies) inquired about the pipeline and returns for community renovation capital expenditures. Stengle described a shift toward larger, more deliberate investments and centralized oversight, expecting strong returns from dozens of upcoming projects.
  • Ben Hendrix (RBC Capital Markets) sought clarity on the impact of pending community dispositions on RevPAR growth and G&A savings. Kussow explained that most remaining assets are small, lower-performing communities and that G&A savings will mostly appear in the second half of the year.
  • Joanna Gajuk (Bank of America) asked about the strategy for new acquisitions, community fees, and pricing power in highly occupied communities. Stengle stated acquisitions will be small and targeted within current markets, while higher occupancy enables greater rate increases and community fees.

Catalysts in Upcoming Quarters

Looking ahead, the StockStory team will be watching (1) whether Brookdale’s new regional leadership structure translates to sustained occupancy and margin improvements, (2) the pace and financial impact of remaining community disposals and targeted capital upgrades, and (3) measurable progress on labor cost containment and turnover reduction. Additional attention will be paid to the effectiveness of the company’s HealthPlus programs in extending resident stays and generating incremental value.

Brookdale currently trades at $12.98, down from $14.18 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).

Our Favorite Stocks Right Now

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  270.13
+0.00 (0.00%)
AAPL  298.87
+0.00 (0.00%)
AMD  445.50
+0.00 (0.00%)
BAC  49.84
+0.00 (0.00%)
GOOG  399.04
+0.00 (0.00%)
META  616.63
+0.00 (0.00%)
MSFT  405.21
+0.00 (0.00%)
NVDA  225.83
+0.00 (0.00%)
ORCL  189.76
+0.00 (0.00%)
TSLA  445.27
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.